The White House Office of National Drug Control Policy (ONDCP) has announced the formation of an Emerging Threats Committee to address evolving and emerging drug threats in the United States. The committee was authorized through the SUPPORT for Patients and Communities Act and will advise ONDCP Director Jim Carroll on emerging threats. Director Carroll emphasized the importance of being prepared to address not only current challenges, but also future threats. The committee, consisting of representatives from various agencies and organizations, will convene on May 22, 2019.